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FragileX syndrome (FXS), themost common formof hereditary
mental retardation, is caused by a loss-of-functionmutation of the
Fmr1 gene, which encodes fragile X mental retardation protein
(FMRP).FMRPaffectsdendriticprotein synthesis, therebycausing
synaptic abnormalities. Here, we used a quantitative proteomics
approach in an FXS mouse model to reveal changes in levels of
hippocampal synapseproteins. Sixteen independentpools ofFmr1
knock-outmice andwild typemicewere analyzedusing two sets of
8-plex iTRAQexperiments.Of205proteinsquantifiedwithat least
three distinct peptides in both iTRAQ series, the abundance of 23
proteins differed between Fmr1 knock-out and wild type synapses
with a false discovery rate (q-value) <5%. Significant differences
were confirmed by quantitative immunoblotting. A group of pro-
teins that are known to be involved in cell differentiation and neu-
rite outgrowth was regulated; they included Basp1 and Gap43,
knownPKC substrates, andCend1. Basp1 andGap43 are predom-
inantly expressed in growth cones and presynaptic terminals. In
line with this, ultrastructural analysis in developing hippocampal
FXS synapses revealed smaller active zones with corresponding
postsynaptic densities and smaller pools of clustered vesicles,
indicative of immature presynapticmaturation. A second group of
proteins involved insynapticvesiclereleasewasup-regulated inthe
FXS mouse model. In accordance, paired-pulse and short-term
facilitation were significantly affected in these hippocampal syn-
apses. Together, the altered regulation of presynaptically
expressed proteins, immature synaptic ultrastructure, and com-
promised short-term plasticity points to presynaptic changes
underlying glutamatergic transmission in FXS at this stage of
development.
Fragile X syndrome (FXS)4 is the most common form of
hereditary mental retardation disease, affecting one in 4000
males and one in 8000 females. Patients suffer from multiple
behavioral problems including cognitive impairments,
impaired visuo-spatial processing, hyperactivity, anxiety,
and in a number of cases, autism and/or epilepsy (1). FXS is
caused by mutations in the Fmr1 gene resulting in the
absence, significant down-regulation, or loss-of-function of
the corresponding protein product, fragile X mental retar-
dation protein (FMRP) (2). In particular, aberrant synapse
function caused by reduced FMRP expression is considered
to be the major factor underlying FXS.
FMRP is expressed abundantly in neurons and travels into
dendritic spines in an activity-dependent manner (3), where it
affects local synaptic protein synthesis and plasticity. FMRP is
an mRNA-binding protein, associated to many types of
mRNAs, encoding both presynaptic and postsynaptic proteins
(4). By controlling several aspects of mRNA biology, e.g. trans-
port, translation, andmetabolism, FMRPmay regulate synaptic
structure and function (5, 6). Indeed, both FXS patients and
Fmr1 knock-out (KO) mice display an abnormal appearance of
generally long and thin dendritic spines that resemble an imma-
ture postsynaptic phenotype (7, 8). Presynaptically, lack of
FMRP significantly affects the motility and dynamics of axonal
growth cone development in hippocampal neurons, and alter-
ations in terminal branching of hippocampal mossy fibers are
found in the Fmr1KOmouse (9, 10). Thus, the effects of FMRP
upon both presynaptic and postsynaptic structure are likely to
alter functional aspects of glutamatergic signaling during syn-
aptic development in Fmr1 KOmice.
Recent studies ofmolecularmechanisms underlying reduced
cognitive function in FXS have focused on glutamatergic syn-
apse function in several brain regions including hippocampus,
cortex, and cerebellum. In these brain areas, long-term synaptic
plasticity is strongly affected. The relationship between
impaired FMRP expression and synaptic plasticity is complex
(11, 12). In the cortex, the absence of FMRP results in reduced
long-term potentiation (13, 14). In the hippocampus and cere-
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bellum, enhancedmetabotropic glutamate receptor-dependent
long-term depression via an increased internalization of mem-
brane-localized AMPA receptors is observed in Fmr1 KOmice
(15, 16). Activity-dependent changes of synaptic efficacy are
encoded by sequential molecular events at the synapse, includ-
ing FMRP-mediated de novo protein synthesis during the late
phase of long-termpotentiation and long-termdepression (17).
Interestingly, in addition, Gq-coupled M1 muscarinic acetyl-
choline receptor-dependent long-term depression requires
protein synthesis and is enhanced in Fmr1 KO mice (18, 19).
However, an overview of synaptic proteins that are affected by
the lack of FMRP and to what extent their expression levels are
altered is largely unknown. Many forms of short-term plastic-
ity, such as synaptic facilitation, are affected by rapid changes
occurring at the presynaptic terminal. FMRP is expressed at
presynaptic sites (20), where it may regulate establishment
and/or maintenance of synaptic connections (21, 22). A direct
relation between the absence of FMRP and its regulated pro-
teins upon synaptic ultrastructure and fast presynaptic-medi-
ated forms of synapse function in Fmr1 KO mice has not been
fully investigated in mammalian neurons.
To address these issues, we have taken a quantitative pro-
teomics approach to reveal changes in the hippocampal syn-
aptic membrane proteome in Fmr1 KO mice as compared
with the wild type (WT) mice during an early developmental
period of synapse formation and refinement. We observed
changes in a group consisting of known regulators of cell
differentiation, filopodia protrusion, and neurite outgrowth
by remodeling the actin cytoskeleton. Increase in their
expression may retain synapses in an immature state, as we
confirmed for Fmr1 KO synapses at the ultrastructural level.
In addition, a second group of presynaptic vesicle-associated
proteins was dysregulated, in line with our observed func-
tional changes in presynaptic plasticity. Our findings show
that changes in the expression levels of synaptic proteins in
the Fmr1 KO mice correlate to changes in both excitatory
synapse structure and excitatory synapse function, demon-
strating a presynaptic locus for mechanisms underlying FXS.
EXPERIMENTAL PROCEDURES
Animals—Fmr1 KO1 mice on a background of C57Bl/6J
from Harlan Netherlands (23), a kind gift of Dr. B. Oostra and
Dr. R. Willemsen, were bred in our facility. Pregnant WTmice
C57Bl/6JOlaHsd were obtained from Harlan Netherlands, and
pups were born in our facility. For the proteomics experiment,
16 Fmr1 KOmice and 16 WT mice were used.
Synaptic Membrane Preparation—Synaptic membranes
from predominately glutamatergic synapses were isolated from
PN14 Fmr1 KO andWTmice as described previously (24, 25).
A short overview of the experimental setup is represented in
Fig. 1. In brief, for each sample, hippocampi from two mice
were pooled and homogenized in a glass Potter-Elvehjem
homogenizer containing 5 ml of ice-cold homogenization
buffer (320mM sucrose in 5mMHepes, pH 7.4) at 900 rpmwith
12 up and down strokes of the piston. The lysate was centri-
fuged at 1000 g, 4 °C, for 10 min. Supernatant was loaded on
top of a sucrose step gradient consisting of 0.85 and 1.2 M
sucrose. After ultracentrifugation at 100,000  g, 4 °C for 2 h,
the synaptosome fraction at the interface of 0.85/1.2 M sucrose
was collected, diluted six times with 5 mM HEPES buffer (pH
7.4), and centrifuged at 80,000 g, 4 °C for 40min. The osmotic
shock of synaptosomes was done by resuspending the pellet in
HEPES buffer and stirring slowly over ice for 15 min. The
resulting synaptic membrane fraction was recovered by ultra-
centrifugation using the sucrose step gradient as outlined
above. Protein concentration was determined by Bradford
measurement. The obtained synaptic membranes were sub-
jected to trypsin digestion and iTRAQ reagent tagging or quan-
titative immunoblotting.
Protein Digestion and iTRAQ Labeling—In two independent
8-plex iTRAQ experiments, we have compared eightWT sam-
pleswith eightFmr1KOsamples. The relatively highnumber of
biological replicas (n 8) facilitates subsequent statistical anal-
ysis. The digestion and iTRAQ labeling of the synaptic mem-
branes have been described in previous studies (24, 25). In
short, for each sample, 75 g of membrane proteins was solu-
bilized in 28l of 0.85% RapiGest (Waters Corp.) reconstituted
with dissolution buffer (iTRAQ reagent kit, AB Sciex). A 2-l
cleavage reagent (iTRAQ reagent kit, AB Sciex) was added and
incubated at 55 °C for 1 h, after which 1 l of Cys blocking
reagent (iTRAQ reagent kit, AB Sciex) was added and samples
were vortexed for 10 min. Subsequently, 5 g of trypsin
(sequencing grade, Promega) was added and incubated over-
night at 37 °C. The trypsinized peptides were then tagged with
iTRAQ reagents dissolved in 85 l of ethanol. After incubation
for 3 h, the samples were pooled and acidified with 10% triflu-
oroacetic acid to pH 2.5–3. After 1 h, the sample was centri-
fuged, and the supernatant was dried in a SpeedVac. We per-
formed two8-plex iTRAQexperiments to cover the 16 samples.
In each iTRAQ experiment, four WT samples were labeled
respectively with iTRAQ reagents 113–116 and four Fmr1 KO
mice samples were labeled respectively with iTRAQ reagents
117–119 and 121 (Fig. 1).
Two-dimensional Liquid Chromatography—The dried
iTRAQ labeled sample was dissolved in 250l of loading buffer
(20% acetonitrile, 10 mM KH2PO4, pH 2.9), whereas 200 l was
injected into a strong cation exchange column (2.1 150-mm
PolySULFOETHYL A column, PolyLC Inc.). Peptides were
eluted with a linear gradient of 0–500 mM KCl in 20% acetoni-
trile, 10 mM KH2PO4, pH 2.9, over 25 min at a flow rate of 200
l/min. Fractions were collected at 1-min intervals and dried in
a SpeedVac. The peptides were redissolved in 20 l of 0.1%
TFA, delivered with a FAMOS autosampler at 30 l/min to a
reverse phase C18 trap column (1 mm  300-m inner diam-
eter column), and separated on an analytical capillary reverse
phaseC18 column (150mm 100m-inner diameter column)
at 400 nl/min using the LC-Packing Ultimate system. The pep-
tides were separated using a linear increase in concentration of
acetonitrile from 6 to 45% in 50 min and to 90% in 1 min. The
eluent was mixed with matrix (7 mg of recrystallized -cyano-
hydroxycinnamic acid in 1ml of 50% acetonitrile, 0.1% TFA, 10
mM ammonium dicitrate) delivered at a flow rate of 1.5 l/min
and deposited off-line to an Applied Biosystems metal target
every 15 s using an automatic robot (Probot, Dionex).
MALDI-MS/MS—The sample was analyzed on an ABI 4800
proteomics analyzer (AB Sciex). Peptide collision induced dis-
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sociation was performed at 2 kV; the collision gas was air.
MS/MS spectra were each collected from 2500 laser shots. Pep-
tides with signal-to-noise ratio above 50 at the MS mode were
selected for an MS/MS experiment; a maximum of 25 MS/MS
was allowed per spot. The precursor mass window was 200
relative to resolution (full width at half maximum).
Protein Identification and Quantitation—To annotate spec-
tra, Mascot (MatrixScience) searches were performed against
the SwissProt database (release 12.6) and the larger but more
redundant National Center for Biotechnology Information
(NCBI) database (release 081003) using the GPS Explorer (AB
Sciex version 3.6). MS/MS spectra were searched against
mouse databases with trypsin specificity and fixed iTRAQ
modifications at lysine residues and N termini of the peptides.
Mass tolerance was 150 ppm for precursor ions and 0.5 Da for
fragment ions; one missed cleavage was allowed. The false dis-
covery rate (percentage) for peptide identification was calcu-
lated using a randomized database. Protein redundancy in the
result files was removed by clustering the precursor protein
sequences at a threshold of 90% sequence similarity over 85% of
the sequence length (blastclust, version 20041205). Subse-
quently, all peptides were matched against the protein clusters;
those that were matched tomore than one protein cluster were
not considered for protein identification and quantification,
leaving only “unique” peptides in the analysis. Only proteins
identified with at least two peptides with a confidence interval
95% (AB Sciex CI, percentage) were considered identified,
and of these proteins, only those with three or more quantifi-
able peptides in both iTRAQexperimentswere included in sub-
sequent quantitative analyses. Peak areas for each iTRAQ sig-
nature peak (m/z 113.1, 114.1, 115.1, 116.1, 117.1, 118.1, 119.1,
121.1) were obtained and corrected according to the manufac-
turers’ instructions to account for the differences in isotopic
overlap.
To compensate for the possible variations in the starting
amounts of the samples, the individual peak areas of each
iTRAQ signature peak were log 2-transformed and normalized
to the total peak area of the signature peak. Peptides with
iTRAQ signature peaks of less than 2000 were not considered
for quantification. Within each experiment, for each peptide,
the peak area in each sample was mean-centered. Protein aver-
ages were calculated from these mean-centered peak areas of
multiple peptides. Finally, the eight mutant and eight wild type
protein means of both experiments were used to calculate the
average difference between WT and Fmr1 KO mice. To assess
whether this difference had occurred by chance due to themul-
FIGURE 1. Setup of the iTRAQ experiments. The hippocampi from two mice were pooled together to obtain enough material as a single sample for
proteomics analysis. Together, synaptic membrane fractions were isolated from 32 animals representing 16 independent pools of samples of Fmr1 KO mice
andWTmice, respectively. Tryptic digests of synaptic membranes from these 16 samples were tagged with two sets of 8-plex iTRAQ reagents. Peptides from
each set of iTRAQ experiments were pooled together, fractionated by two-dimensional liquid chromatography, and subjected to tandemmass spectrometric
analysis. Protein identification and quantification were performed as detailed under “Results”.
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tiple testing problem or could be deemed significant, we calcu-
lated the permutation-derived false discovery rate (q-value)
using the Excel plug-in of the Significance Analysis of Microar-
rays (SAM) program (26, 27). The settings for the SAM pro-
gram were: two class unpaired, log 2-scaled, t-statistic, 1000
permutations, automatic estimation of s0 factor, 10 k-nearest
neighbors.
Immunoblotting—Samples were mixed with SDS sample
buffer and heated to 90 °C for 5 min. Proteins were separated
on an SDS-polyacrylamide gel in a Mini-PROTEAN electro-
phoresis system (Bio-Rad) and electroblotted onto the PVDF
membrane overnight at 40 V. Membranes were incubated
with primary antibodies followed by an alkaline phospha-
tase-conjugated secondary antibody (Dako; 1:1000). The sig-
nal was developed with ECF substrate (GE Healthcare); the
image was scanned with an FLA 5000 instrument (Fujifilm)
and analyzed with Quantity One software (Bio-Rad). The
following antibodies were used: mouse anti-calcium/cal-
modulin-dependent protein kinase type II subunit  (Zymed
Laboratories Inc.; 1:1000), mouse anti-PSD-95 (Abcam;
1:1000), mouse anti-glutamate receptor (NMDAR1) (BD
Biosciences; 1:1000), rabbit anti-syntaxin 1B (gift from
M. Verhage; 1:1000), rabbit anti-synaptophysin (gift fromM.
Verhage; 1:2000), rabbit anti-synapsin I and II (gift from M.
Verhage; 1:1000), rabbit anti-NAP-22 (Basp1) (Chemicon;
1:1000), rabbit anti-BM88 (Cend1; gift from R. Matsas;
1:2000), and mouse anti--catenin (BD Biosciences; 1:1000).
Ultrastructure Analysis by Electron Microscopy—Mice (n 
3/genotype) were subjected to transcardiac perfusion with a
mixture of glutaraldehyde (2.5%) and paraformaldehyde (4%) in
0.1 M cacodylate buffer, pH 7.4. From the fixed brain, 50-m-
thick coronal slices containing the stratum radiatumwere post-
fixed (1% OsO4) and stained with 1% uranyl acetate. After
embedding in Epon, ultrathin sections (90 nm)were collected
on 400-mesh copper grids and stained with uranyl acetate and
lead citrate. For each condition, docked vesicles, total vesicle
number, postsynaptic density (PSD), active zone (AZ) length,
and vesicle cluster surface (nm2) were measured on digital
images taken at 100,000magnification using software in indi-
vidual electron micrographs, in which a single synapse was
counted from each of the three perfusion-fixed mice per geno-
type using a Jeol (Peabody,MA) 1010 electronmicroscope. The
observer was blind to genotype during the procedure.
Electrophysiological Analysis of Miniature Excitatory Post-
synaptic Currents (mEPSCs)—Horizontal hippocampal brain
slices (300 m thick) were prepared from 13–15-day-old WT
and Fmr1KOmice. Brains were rapidly removed and dissected
in ice-cold artificial cerebrospinal fluid containing (inmM): 125
NaCl; 3 KCl; 1.25NaH2PO4; 3MgSO4; 1 CaCl2; 26NaHCO3; 10
glucose (300mosM). Slices were cut on a vibratingmicrotome
and placed in artificial cerebrospinal fluid in a submerged-style
holding chamber, bubbled with carbogen (95% O2, 5% CO2)
containing the following (in mM): 125 NaCl; 3 KCl; 1.25
NaH2PO4; 1 MgSO4; 2 CaCl2; 26 NaHCO3; 10 glucose.
Slices were left for 1 h to recover before recording began.
Tetrodotoxin (1 M) was added to the recording artificial cere-
brospinal fluid (same as holding chamber), and slices were per-
fused in a submerged recording chamber at 28–32 °C.
SR-95531 (gabazine, 10 M, Tocris) was added to the bath to
block GABAA receptor-mediated synaptic currents. Whole-
cell patch clamp recordings were made from pyramidal cells in
the CA1 region under visual guidance by differential interfer-
ence contrast microscopy. Patch pipettes (3–5 megaohms)
were pulled from standard-wall borosilicate tubing and were
filled with intracellular solution containing the following (in
mM): 140 potassium gluconate; 9 KCl; 10 HEPES; 4 K2-phos-
phocreatine; 4 ATP (magnesium salt); 0.4 GTP (pH 7.2–7.3, pH
adjusted with KOH; 290–300 mosM). For recording mEPSCs,
cells were held in a voltage clamp and recorded for on average 8
min at 70 mV. Events were analyzed using Mini Analysis
(Synaptosoft, NJ) with event detection levels for synaptic cur-
rents set at 8 pA. Rise and decay times were calculated from
average event fits. Statistical comparisons were made using
analyses of variance with post hoc t tests and Levene’s analysis
of variance as appropriate in SPSS softwarewith p values 0.05
being considered statistically significant. Synaptic current
parameters are reported as mean S.E.
Electrophysiological Analysis of Short-term Plasticity—Hori-
zontal hippocampal brain slices (300 m thick) were prepared
from 14–18-day-oldWT and Fmr1 KOmice, and CA1 pyram-
idal cells were selected and recorded as described previously for
mEPSCs but without the addition of tetrodotoxin to artificial
cerebrospinal fluid. Patch pipettes were filled with intracellular
solution containing the following (in mM): 129 cesium gluco-
nate; 1 CsCl; 10 HEPES; 4 K2-phosphocreatine; 10 tetraethyl-
ammonium; 4ATP (magnesium salt); and 0.4GTP (pH7.2–7.3,
pH adjusted to 7.3 with CsOH; 290–300 mosM). After whole-
cell configuration, the membrane potential was held at 70
mV, and the internal solution was allowed to diffuse for 5 min
into the cell prior to the onset of recording. The low intracellu-
lar chloride concentration in the pipette allowed identification
and exclusion of experiments in which inhibitory events
occurred close to the EPSCs measured.
Schaffer collateral fibers were stimulated using an extracel-
lular electrode positioned in the stratum radiatum on the CA3
side. Moderate stimulation was used to measure synaptic facil-
itation or depression in response to presynaptic trains (of up to
10 pulses) over a range of frequencies (5–50 Hz). For each fre-
quency, the stimulus train was repeated 20 times, with a 15-s
delay between each sweep. Sweeps at each frequency were
equally divided into two groups, one at the start and one at the
end of the experiment, allowing time-dependent changes in the
responses to be identified. Synaptic currents sampled at inter-
vals of 100 s were digitized and analyzed off-line as described
previously (28). To assess significance, analysis of variance with
repeated measures was used (for within subjects effect test,
Huynh-Feldt was used after Mauchly’s test for sphericity) as
well as post hoc unpaired Student’s t test. Data are given as
mean S.E., with p 0.05 indicating significance.
RESULTS
MS/MS Analysis, Protein Identification, and Quantification—
To reveal the molecular basis of synapse dysfunction that
underlies the FXS phenotype, we compared the proteomes of
the synaptic membrane fractions of hippocampus from Fmr1
KO and WT mice. In previous studies, we showed the robust-
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ness of the synaptic proteome to resist perturbation, which
argues for the use of a large sample size to detect subtle changes
(24, 25). Therefore, we analyzed eight independent pools of
both Fmr1 KO and WT mice. Altogether 50,000 MS/MS
analyses were performed, and 347 proteins were identified with
at least two distinct peptideswith a confidence of95%present
in both iTRAQ experiments. The false discovery rate (percent-
age) for peptide identification using randomized database from
NCBI and SwissProtwas about 2% (the false discovery rate from
the first iTRAQexperiment is 1.6% forNCBI and 2.1% for Swis-
sProt; for the second iTRAQ experiment, it is 1.9 and 2.1%,
respectively). As iTRAQ-based quantitation relies on the
iTRAQ signature peak intensities generated fromMS/MS anal-
ysis of a single selected parent ion, the presence of a co-eluting
but distinct peptide of similar mass would contribute to the
noise depending on the intensity and mass difference of the
interfering peptide. For the sake of increased reliability of quan-
tification of protein abundance, we focused on proteins with
3 distinct peptides in both iTRAQ experiments (n  205,
supplemental Table 1). The observed -fold changes were low
with the largest difference of 1.24-fold (Table 1; log 2  0.31),
but these were similar as observed previously for relevant bio-
logical changes (29). Using the Significance Analysis of
Microarray program (SAM, q-value) (27) with false discovery
rate 5%, 23 proteins were considered to be significantly dif-
ferent betweenKOandWTmice.Among them, several presyn-
aptic proteins were present, including syntaxin, synapsin, syn-
aptophysin, piccolo, Rab3A, and vacuolar proton pump subunit
E, as well as proteins involved in cell differentiation/neurite
outgrowth including Cend1, Basp1, and Gap43.
Confirmation of iTRAQ Data by Immunoblotting—Quanti-
tative immunoblotting analysis was performed to verify the
quantitative proteomics data obtained by iTRAQ. Fig. 2 shows
the good agreement between the two methods, i.e. syntaxin,
synapsin, synaptophysin, Basp1, Cend1, and Ctnnb1 (q 5%)
showed significant difference by immunoblotting (p  0.05),
whereas calcium/calmodulin dependent protein kinase type II
subunit  (Camk2), N-methyl-D-aspartate receptor subunit
NR1 (Grin1), and PSD-95 (Dlg4) (q 5%) failed to show
changes by immunoblotting.
Ultrastructural Analysis of Synapses from the Hippocampal
CA1 Region—The proteomics data implicate a dysregulation of
proteins localized to the presynaptic compartment in Fmr1KO
mice (Table 1). The up-regulation of presynaptic proteins could
be due to amismatch betweenAZ and PSD size, a higher number
of docked vesicles, or a change of protein composition of synaptic
vesicles. To obtain insight into the subcellular changes of synapses
correlated with these dysregulated proteins, we performed an
ultrastructural analysis using electron microscopy (Fig. 3, a–d).
We found that theAZ length of the presynaptic elements in Fmr1
KOmicewasshorterby19%(p0.000141)ascomparedwithWT
mice (Fig. 3e).A similardecreasewasobserved for the lengthof the
PSD of 16% (p 0.00046) (data not shown). When the PSD was
normalized to the AZ length, there was no difference between
Fmr1 KO and WT animals with both lengths shortened accord-
ingly, resulting inasmaller synaptic structure in theFmr1KOmice
TABLE 1
Proteins with significant changes in the hippocampal synaptic membrane fraction of Fmr1 KOmice
The proteins with at least three distinct peptides in both iTRAQ experiments with the q-values 5% are shown. The accession number for each protein is indicated.
Furthermore, the total number of peptides identified, the coverage of the protein, the -fold difference, and the corresponding standard deviation between Fmr1 KO mice
and WT mice are shown. CI, confidence interval; SAM, Significance Analysis of Microarrays program.
UniProt accession
number Protein name
% of coverage
of the protein
No. of
peptides
CI> 95%
Difference
KO-WT
(log 2 scale)
Standard
deviation
KO-WT
(log 2 scale)
q-value (%)
using SAM
Cell differentiation/neurite outgrowth
Q91XV3 Brain acid-soluble protein 1 58.1 11 0.31 0.20 0.00
Q9JKC6 Cell cycle exit and neuronal differentiation
protein 1
61.3 7 0.27 0.18 0.00
Q02248 Catenin -1 31.1 19 0.16 0.12 0.00
P18760 Cofilin-1 55.7 7 0.13 0.11 0.00
P06837 Gap43 86.8 14 0.23 0.23 0.00
Presynaptic transmission
P61264 Syntaxin-1B2 52.6 11 0.16 0.14 0.00
P63011 Ras-related protein Rab-3A 30.3 5 0.15 0.13 0.00
Q9QYX7 Protein piccolo 8.1 17 0.13 0.12 1.80
O88935 Synapsin-1 46.1 22 0.11 0.12 3.50
Q62277 Synaptophysin 21.0 5 0.12 0.14 3.50
Q9DBG3 AP-2 complex subunit -1 8.6 5 0.15 0.19 3.50
P50518 Vacuolar ATP synthase subunit E 47.6 9 0.18 0.14 0.00
Mitochondrial/metabolic proteins
Q9CR68 Ubiquinol-cytochrome c reductase iron-sulfur
subunit
30.2 7 0.15 0.12 0.00
O35143 ATPase inhibitor, mitochondrial precursor 28.0 3 0.19 0.15 0.00
Q9WUA3 6-Phosphofructokinase type C 16.9 8 0.13 0.10 0.00
Q9CQ69 Ubiquinone-binding protein QP-C 54.2 5 0.17 0.17 0.00
P17182 -Enolase 29.2 10 0.14 0.15 1.80
P05064 Fructose-bisphosphate aldolase A 74.2 19 0.13 0.14 1.80
P16858 Glyceraldehyde-3-phosphate dehydrogenase 43.4 11 0.12 0.11 1.80
Q9CPQ8 ATP synthase subunit g, mitochondrial 59.6 4 0.14 0.13 1.80
Other
P17742 Peptidyl-prolyl cis-trans isomerase A 81.2 11 0.17 0.14 0.00
P05132 cAMP-dependent protein kinase, -catalytic
subunit
15.3 3 0.18 0.18 0.00
P58252 Elongation factor 2 15.0 5 0.18 0.15 0.00
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(Fig. 3f). In addition, this result excludes the possibility that amis-
matched ratio between active zone and PSD length leads to up-
regulation of presynaptic proteins.
Furthermore, by counting synaptic vesicles, we observed that
there was a trend for a higher number of docked vesicles per AZ
length in the Fmr1 KO mice (Fig. 3g), the value of 10% being
similar to the observed changes in protein regulation 10%.
The number of vesicles per cluster surface in Fmr1 KO mice
was significantly decreased (p 0.00413) (Fig. 3h). As a result,
the fraction of docked vesicles per total number of vesicles in
FIGURE 2. Immunoblot analysis of selected synaptic proteins from Fmr1 KO and WT mice. a, the gene names of the proteins and the corresponding
immunoreactive bands on the Western blots made from the WT and KO mice synaptic membrane samples are shown. b, the average intensity of the
immunoreactive bands for each protein measured in the Fmr1 KO (gray bars) is normalized to that of the WT group (black bar; set to 100%, control). c, the
Student’s t test p value of the immunoblot analysis (n 5) and corresponding q-valuesmeasured by iTRAQ-basedquantitative proteomics are shown. p values
below 0.005 are indicated as 0.00.
FIGURE 3.Ultrastructural analysis of CA3 toCA1 synapses in the stratumradiatum. a–e, Fmr1KO (a andb) as comparedwithWT (c and d) animals revealed
a smaller length of theAZ (e). f andg, no significant differenceswere observed for the ratio of PSD toAZ length (f;p 0.154), and thenumber of docked vesicles
perAZ length (g;p0.375).h and i, Fmr1KOmice showed fewer vesicles per cluster surface (h) andan increaseof the ratio of docked to total number of vesicles
(i) indicative for their immature phenotype. Data aremean S.E. The analysis consisted of n 86–87 Fmr1KOand n 68–71WT synapses from three animals
per genotype. **, p 0.01; ***, p 0.001 using a Newman-Keuls test. Norm. PSD, normalized PSD.
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the presynapse was increased in Fmr1 KOmice (Fig. 3i). Taken
together these data suggest that synapses of Fmr1 KOmice are
less developed as compared with WTmice. More importantly,
these results provide clear ultrastructural evidence for a presyn-
aptic phenotype in the CA1 region of hippocampus.
mEPSCs to Determine Basic Parameters of Vesicle Release—
The changes in presynaptic morphology and global changes in
presynaptic protein levels are suggestive for changes in presyn-
aptic function and plasticity and prompted us to test whether
these structural alterations are reflected in changes in the basic
quantal units of synaptic transmission. We measured mEPSCs
from hippocampal slices of 2-week-oldWT and Fmr1KOmice
(Fig. 4a). We observed no differences in baseline parameters of
amplitude (WT  14.7  1.0 pA; Fmr1 KO  12.9  0.7 pA),
charge transfer (WT 204 30 pAms; Fmr1 KO 194 16
pAms), or frequency (Fmr1KO 0.2 0.03Hz;WT 0.19
0.03 Hz) of responses between the two groups (WT, n  15;
Fmr1 KO, n 14; Fig. 4, b–d). Furthermore, we found no dif-
ference in rise (WT 1.5 0.2 ms; Fmr1 KO 1.6 0.2 ms)
or decay times (WT 9.8 2.5ms; Fmr1KO 12.7 2.9ms)
of the mEPSCs between the two groups. The absence of effect
upon baseline parameters of synaptic amplitude and frequency
indicates that no detectable changes in synapse strength, gluta-
mate release probability, or vesicle release occur in Fmr1 KO
pyramidal neurons under baseline conditions at this develop-
mental stage.
Short-term Plasticity—Because we did not observe any effect
on basic quantal units of synaptic transmission, we investigated
whether the observed changes in presynaptic proteins and the
increased fraction of docked vesicles per total number of vesi-
cles in Fmr1 KO mice might affect the rapid dynamics of syn-
aptic plasticity. For this, we performed paired-pulse and short-
term facilitation on Schaffer collateral inputs onto CA1
hippocampal pyramidal cells (Fig. 5a). Paired-pulse facilitation
was significantly lower in Fmr1 KO mice than in WT mice in
response to low frequency synaptic input (50-ms interpulse
intervals; PPR WT  1.38  0.07, n  19; PPR Fmr1 KO 
1.21  0.04, n  23; p  0.016 (Fig. 5, b–d), or 100-ms inter-
pulse intervals; PPRWT 1.37 0.1, n 19; PPR Fmr1KO
1.13 0.04, n 23; p 0.034 (Fig. 5d)). This decreased facili-
tation at low input frequencies of 10–20 Hz was also observed
when the amplitudes of all the EPSC responses in a train (Fig.
6a) were analyzed (50ms;WT 1.28 0.1, Fmr1KO 1.05
0.05, p  0.03; 70 ms; WT  1.31  0.11, Fmr1 KO  1.08 
0.06, p 0.048; 100 ms; WT 1.29 0.1, Fmr1 KO 1.05
0.06, p  0.037; WT, n  19, Fmr1 KO, n  23; Fig. 6, b–e).
Similar significant differences were also observed with shorter
trains of five pulses between 20- and 200-Hz stimulation fre-
quency input (supplemental Fig. 1). Kinetic parameters of first
and second pulses during paired-pulse facilitation at 50-ms
time intervals between WT (n  11) and Fmr1 KO (n  12)
mice showed no significant differences between rise (analysis of
variance p  0.59) and decay times (analysis of variance p 
0.68) of first (P1) and second (P2) pulses for WT and KO
recordings (supplemental Fig. 2). Meanwhile, at higher stimu-
lus frequencies, the degree of paired-pulse facilitation and the
degree of facilitation during the EPSC train became more sim-
ilar in WT and Fmr1 KO mice (Fig. 6b). Thus, although basal
transmission remains unchanged, the short-term dynamics of
the Schaffer collateral input are significantly altered over a spe-
FIGURE 4. No significant differences in mEPSCs between CA1 pyramidal
neurons of 2-week-old WT and Fmr1 KOmice. a, averaged traces of mEP-
SCs held at 70 mV from Fmr1 KO (black) and WT neurons (gray). b–f, no
significant differences were observed betweenmean amplitude (Amp), area,
frequency, rise time, or decay time of events recorded for WT (n  15) and
Fmr1KO (n14)mice.MeanS.E. is shownwith individual datapoints to the
right.
FIGURE 5. Paired-pulse ratio is affected in Fmr1 KO mice. a, schematic
showing the short-term plasticity protocol. Schaffer collateral fibers were
stimulated (Stim) using a 10-pulse variable frequency, and the stimulation
train and EPSCs were recorded (Rec) in CA1 pyramidal cells. b, example of
single experiments (50-ms interpulse interval) showing paired-pulse facilita-
tion in response to the first two stimuli in the train (arrowheads). EPSCs are
averaged responses from 20 sweeps (stimulus artifacts truncated). c, paired-
pulse facilitation in WT and Fmr1 KO pyramidal cells (interpulse interval; 50
ms). Each pair of points (connected by gray lines) shows the average first and
second EPSCs from individual experiments (mean of 20 stimulus trains).
Points connected by a thick black line show group averages. d, effect of inter-
stimulus interval on paired-pulse facilitation. PPR is plotted against the inter-
pulse interval (each point shows the mean S.E., *, p 0.05, **, p 0.01).
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cific 10–20-Hz range of synaptic input frequencies to CA1
pyramidal cells.
DISCUSSION
In this study, we investigated levels of synaptic proteins,
ultrastructure, and the physiology of the synapses in the hip-
pocampus of Fmr1 KO mice, a model for FXS. Although the
mRNA targets of FMRP have been well characterized in neuro-
nal synapses in brain tissue, it is not known how this is reflected
in a dysregulated synaptic proteome. We first took a quantita-
tive approach using 8-plex iTRAQ reagents in conjunctionwith
LC-LC MALDI MS/MS analysis to compare the proteomes of
hippocampal synapticmembrane fractions fromWT and Fmr1
KO mice. The high number of independent biological samples
(n 8) was instrumental in revealing subtle, statistically signif-
icant differences in protein levels of the synaptic proteome.
Indeed, small differences are observed that have been reported
to have significant physiological and/ormorphological implica-
tions for FXS (7, 16, 30–32). Interestingly, only one of the dif-
ferentially expressed proteins, Basp1, has been reported as an
mRNA target of FMRP. This protein is implicated in regulation
of cell morphology via the modulation of actin dynamics,
together with e.g. Gap43, and both show increased levels in
Fmr1KOmice. These proteins are cytoskeleton-associated and
regulate actin dynamics through a similar mechanism (33, 34).
Their regulatory roles in actin dynamics may contribute to
molecular mechanisms underlying neuronal development of
Fmr1 KO mice by influencing synapse morphology. The
expression of Basp1 and Gap43 is developmentally regulated
and is high in axons during outgrowth and regeneration. Over-
expression of Gap43 and Basp1 has been shown to promote
axon sprouting (33). Taken together Basp1 andGap43 are likely
to be important regulators of synapse morphology via remod-
eling of the actin cytoskeleton. In agreement with this, a down-
stream effector of actin dynamics, cofilin-1, was also dysregu-
lated inKO synapses. Indeed, dysregulated actin dynamics have
been proposed previously as an important factor in FXS (35,
36). In addition, Cend1, a protein important for cell differenti-
ation, is significantly up-regulated. Cend1 is expressed
throughout all brain regions with a high level in the hippocam-
pus. It is involved in neuronal differentiation in the developing
embryonic brain and was shown to enhancemorphological dif-
ferentiation of mouse neuroblastoma cells in vitro (37, 38).
Thus, Cend1 up-regulationmay represent an upstream effector
underlying the altered hippocampal synapse morphology in
Fmr1 KO mice. Previous studies in the Drosophila model of
FXS are in agreement with our findings; the Drosophila fragile
X gene dFXR was shown to negatively regulate neuronal elab-
oration and synaptic differentiation, whereas overexpression
had the opposite effect (39).
The down-regulation of -catenin we observed in the Fmr1
KO synapses may have both structural and functional implica-
tions for hippocampal neurons. -Catenin is involved in activ-
ity-dependent synaptic remodeling and gene transcription (40)
and is present in both the presynaptic active zone and the post-
synaptic density. Deletion of -catenin in the presynaptic ter-
minal has been shown to reduce the reserve pool of synaptic
vesicles, resulting in synaptic depression during repeated stim-
ulation (41). In facilitating synapses between CA3-CA1 hip-
pocampal neurons, we observed a significantly reduced facili-
tation in Fmr1 KO mice. In addition, ablating -catenin in the
postsynaptic neuron results in thin and elongated immature
spines (42), an observation in line with the immature ultra-
structural findings we reported, and has been observed inmany
brain regions in Fmr1 KOmice (7).
In the present study, we showed that specific synaptic vesicle
proteins were up-regulated in the synaptic membrane prepara-
tion of Fmr1 KO mice. Previous studies examined long-term
plasticity with an underlying postsynaptic locus in Fmr1 KO
synapses and revealed significant impairments in long-term
potentiation (28). We wished to test whether glutamate release
and its short-term dynamics were altered by regulation of pro-
teins in the axon terminal of KO neurons. Recording mEPSCs
samples synaptic currents from all regions of the dendrite,
including basal and proximal branches of a neuron. We found
no basal changes in mEPSCs at these synapses, in line with
observations at other hippocampal and cortical synapses (43–
45). However, the short-term dynamics of this Schaffer collat-
eral input pathway were significantly modified. In Fmr1 KO
mice, the response to a second stimulus in a paired-pulse ratio
was significantly lower than in WT mice. Paired-pulse facilita-
tion is generally acknowledged to have a presynaptic locus;
thus, the lower ratio in Fmr1 KOmice points toward a presyn-
aptic defect in function. In line with these findings, the smaller
AZ and PSD observed in Fmr1 KO synapses together with the
overall decrease in numbers of synaptic vesicles and down-reg-
ulation of -catenin correlate with the reduced ability of the
synapse to respond to rapid, repeated stimulation. Further-
more, these synapses were also impaired in their facilitating
response to a train of synaptic stimuli in Fmr1 KO, at inter-
FIGURE 6.Hippocampal short-term synaptic plasticity is affected in Fmr1
KOmice.a, example singleexperiments (100-ms interpulse interval) showing
short-term synaptic plasticity in response to a 10-pulse stimulus train (arrow-
heads). EPSC trains are the averaged responses from 20 sweeps (stimulus
artifacts truncated).b, averaged synaptic facilitationduring the stimulus train.
Each point represents the averaged EPSC amplitude from all 10 pulses, nor-
malized to the amplitude of the first EPSC in the train (bars show average
(Train avg) S.E.). c–e, facilitation is reduced in Fmr1 KO mice, with low fre-
quency synaptic input. Interpulse intervals are as follows: 100 (c), 70 (d), and
50 (e) ms. Each point shows the EPSC amplitudes, averaged from 20 sweeps,
normalized to the amplitude (Amp (Norm)) of the first EPSC (*,p0.05; **,p
0.01; bars show S.E.).
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stimulus intervals of between 50 and 100ms. This physiological
range of stimulus frequencies could reflect an altered process-
ing of the hippocampal network as a whole during -frequency
(10–20 Hz) activity, as observed during hippocampal oscilla-
tions (46).
In our study, all proteomics analysis, electrophysiology, and
electron microscopy were carried out at 2 postnatal weeks of
development. Postnatal age has a significant effect upon the
alteration in spine morphology reported in the Fmr1 KO
mouse; in sensory cortex, abnormalities are observed in spine
length at both 1 and 2 postnatal weeks, but not at 4 weeks old
(7). The dendritic spine abnormality returns, however, later
than 4 weeks of age in the cortex (47). Synaptic function in the
somatosensory barrel cortex is also age-dependent, with signif-
icantly altered synaptic AMPA and NMDA ratios being
observed during the 1st postnatal week but normalizing by 2–3
weeks of postnatal age (32). Thus, the alterationswe observed at
this key period for spine formation and pruning could be
restricted to specific developmental time points. Indeed, no
changes have been observed in PPR ratios in adolescent (4–6
weeks) Fmr1 KO mice as compared with WT mice (48), thus
showing evidence that theremay be critical developmental time
windows for the specific effects of FMRP upon hippocampal
synapse structure and resulting function.
Although our data from three differing techniques reveal
clear presynaptic changes, it does not rule out additional post-
synaptic factors from affecting the synapse at this developmen-
tal age. Both NMDA and AMPA receptor subunits showed
slight small down-regulation in our Fmr1 KO samples, but the
changes were not statistically significant. Previous studies
reported no overall changes in NMDA and AMPA receptors in
the hippocampus of Fmr1 KO1mice (14, 49), but only signaling
via an mGluR5-mediated activity-dependent increase in
AMPA receptors internalization in Fmr1 KO mice (15, 16).
Alteration of other signal transduction pathways, especially the
decrease in production of cAMP, has been reported in several
model systems of FXS (50). We detected an increase in PKA
levels in Fmr1 KO synapses, which may in part compensate for
a decreased production of cAMP.
In our experiments, we used the Fmr1KO1mousemodel for
FXS, which is in widespread usage and has a total absence of
FMRP but traces of Fmr1 mRNA. One recent study using an
“Fmr1 KO2” mouse model that is deficient in both Fmr1 RNA
and FMRP showed opposing changes in synaptic function as
compared with other current research in the field (16). Also, in
contrast to our study using Fmr1 KO1 mice, Pilpel et al. (16)
observed a normal paired-pulse ratio. These observations
might point to the importance of the remaining levels ofmRNA
of Fmr1 in the conventional Fmr1KO1model in the regulation
of synapse function.
In conclusion, our quantitative proteomics data set reports
the global changes in FMRP-regulated expression at this critical
point in hippocampal synapse development. Regulation of spe-
cific proteins with presynaptic vesicle and morphological
growth function correlate with the ultrastructural changes we
observed in synaptic vesicles and active zone size at the EM
level in Fmr1 KO synapses. These changes can be attributed to
the absence of FMRP during early development of the hip-
pocampus. Alteration in protein expression and immature
morphology at presynaptic loci correlate with impairments in
rapid functional dynamics of short-term plasticity. In combina-
tion,we propose that these abnormalities show clear alterations
of presynaptic structure and function in the Fmr1 KO mouse
and contribute to the underlying molecular basis of hippocam-
pal deficits in FXS.
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